Correction to: Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT).
Catherine R HannaSean Michael O'CathailJanet S GrahamMark SaundersLeslie M SamuelMark HarrisonLynsey DevlinJoanne EdwardsDaniel R GayaCaroline A KellyLiz-Anne LewsleyNoori MakaPaula MorrisonLouise DinnettSusan DillonJacqueline GourlayJonathan J PlattFiona ThomsonRichard A AdamsCampbell Stuart RoxburghPublished in: Radiation oncology (London, England) (2021)